Clinical Trial Update: Attenuation Corrected Cardiac SPECT Using the GE Hawkeye Camera System [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating attenuation-corrected cardiac SPECT with the GE Hawkeye camera for cardiac disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Snippet

Sponsor: Mayo Clinic | Conditions: Cardiac Disease | Phase 2, Phase 3 | Status: TERMINATED